Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine

Van Regenmortel M.H.V. (2011)

Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to:

Article in Press

Please refer to this item in SUNScholar by using the following persistent URL:
This item appears in the following collections: